NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	type 2 diabetes mellitus
Date of first enrollment	12/01/2012
Target sample size	420
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : JTT-851 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral control material(s) Generic name etc : Placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Oral Generic name etc : Glimepiride INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	HbA1c (12weeks)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 75age old
Gender	Both
Include criteria	A historical diagnosis of type 2 diabetes mellitus A glycosylated hemoglobin level between 7.0% and 10.0%
Exclude criteria